{
    "2018-12-27": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Teva Stock Rises on Patent Settlement With Neos Therapeutics",
                "features": {
                    "keywords": [
                        "Teva",
                        "Patent Settlement",
                        "Neos Therapeutics"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-20",
                "original_text": "Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",
                "features": {
                    "keywords": [
                        "J&J",
                        "Drug Stocks",
                        "Buy Recommendation"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-22",
                "original_text": "Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL",
                "features": {
                    "keywords": [
                        "Innovent",
                        "Lilly",
                        "Tyvyt",
                        "NMPA Approval",
                        "CHL"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}